ADAPTIVE PHAGE THERAPEUTICS
DEAD

Serial Number

97705243

Owner

Adaptive Phage Therapeutics, Inc.

Attorney

Leesa N. Weiss

Filing Date

Dec 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ADAPTIVE PHAGE THERAPEUTICS Trademark

Serial Number: 97705243

ADAPTIVE PHAGE THERAPEUTICS is a trademark filed by Adaptive Phage Therapeutics, Inc. on December 6, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Adaptive Phage Therapeutics, Inc. (25 trademarks)

Gaithersburg, MD 20878

Entity Type: 03

Trademark Details

Filing Date

December 6, 2022

Registration Date

Not Registered

Published for Opposition

December 12, 2023

Goods & Services

custom manufacture of pharmaceuticals in the nature of bacteriophage therapeutics

computer software system comprised of downloadable computer software for identifying precision therapy for treatment of bacterial infections

human, animal, plant and microorganism biological preparations for use in disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the field of medicine; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity; diagnostic kits comprising reagents for testing bacteria sensitivity for medical or veterinary use; bactericides comprised of biological preparations for treating bacterial infections and bacterial contamination in the fields of farming and food preparation; bactericides comprised of biological preparations for treating bacterial contamination in the industrial and food preparation fields

diagnostic reagents for clinical and medical laboratory use; human, animal, plant and microorganism biological preparations for use in industry and science, namely, for use in drug development

refrigerators and freezers for medical storage purposes

computer software system comprised of temporary, online non-downloadable computer software for identifying precision therapy for treatment of bacterial infections

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 9, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 9, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 6, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 12, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 7, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 7, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 7, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 7, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 15, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 15, 2023 XELR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 4, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 4, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 4, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 4, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 4, 2023 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 16, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 16, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 16, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 5, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2023 NWOS
NEW APPLICATION ENTERED
Dec 9, 2022 NWAP